Head-to-head · WeighScore
Peter MD vs Vitara RX
By GLP-1 ScorecardUpdated
Score comparison
Vitara RX has the higher recorded score — 86/100 to 78.1/100.
Vitara RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded GLP-1 marketplace with conflicting advertised prices and unresolved shipping-policy details.
Before you choose
Before comparing the headline prices, the Peter MD review and the Vitara RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Big Easy Weight Loss vs Peter MD and Pomegranate Health vs Vitara RX compare each of them with another graded program, and the list of alternatives to Peter MD ranks the programs closest to Peter MD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Peter MD | Vitara RX |
|---|---|---|
| WeighScore | 78.1/100 | 86/100 |
| Grade | C+ | B |
| Site position | #32 | #10 |
| Semaglutide | From $149/month advertised with B12; other page prices differ; confirm charge and renewal | Advertised from $99/month with an annual plan and discount code ($279 reference); conflicting displays—confirm selected charge. |
| Tirzepatide | From $149/month with B12; $100 off first month advertised; renewal unconfirmed | Advertised from $198/month with an annual plan and discount code ($389 reference); conflicting displays—confirm selected charge. |
| Coverage | Confirm availability for the specific GLP-1 prescription and shipping state | Site lists 49 states, Alaska omitted; confirm medication-specific availability |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #32 · C+
Strengths
- Dedicated offers advertise consultations, supplies, shipping and membership together
- Public pages name pharmacy possibilities and disclose an email cancellation window
- Laboratory testing is advertised at 50% off
What to consider
- Starting prices do not establish the renewal; main-site price displays differ
- Specific GLP-1 state eligibility, assigned clinician and dispensing pharmacy remain unconfirmed
- Labs are discounted rather than free; GLP-1-specific monitoring and total testing cost remain unclear
- Auto-renewal cancellation requires at least 48 hours’ email notice; sales are final once medication is received
- Clinical rejection and unused-prepayment refund terms remain unresolved
Strengths
- Named compounded semaglutide and tirzepatide offerings
- Ongoing provider messaging advertised
- Terms allow directing prescriptions to another pharmacy
What to consider
- Prices changed with a November site rebuild; annual-plan and discount-code conditions need confirming
- FAQ, terms and returns pages cited earlier no longer load
- Published list omitted Alaska
- Refrigeration instructions conflict with the returns policy
- No universal lab schedule or testing price established
- Website policy descriptions leave clinical and dispensing roles unclear
Featured provider
Peter MD
Peter MD scores 78.1/100 (C+). Peter MD advertises B12 injection packages with consultations, supplies and shipping, but its public price displays differ and the ongoing GLP-1 charge needs a written quote.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.